Medical device surveillance: gender differences in pulmonary artery rupture after pulmonary artery catheterization

Ronald G Kaczmarek1, Chih-Hsin K Liu, Thomas P Gross

  • 1Center for Devices and Radiological Health, Food and Drug Administration, 1350 Piccard Drive, Rockville, MD 20850, USA. rxk@cdrh.fda.gov

Insights

Pulmonary artery (PA) rupture is a rare but fatal complication of PA catheterization. This study found women are at significantly higher risk for PA rupture than men, necessitating clinical awareness.

Area of Science:

  • Cardiology
  • Medical Devices
  • Patient Safety

Background:

  • Pulmonary artery (PA) rupture is a rare, life-threatening complication associated with PA catheterization.
  • Understanding risk factors is crucial for preventing adverse outcomes.

Purpose of the Study:

  • To investigate the incidence and characteristics of PA rupture following PA catheterization.
  • To identify potential demographic risk factors for this complication.

Main Methods:

  • Analysis of 71 PA rupture case reports from the FDA's Medical Device Reporting (MDR) system (1991-2001).
  • Examination of the Nationwide Inpatient Sample (NIS) database for PA catheter use patterns.
  • Statistical analysis to compare rupture rates between genders.

Main Results:

  • 71 cases of PA rupture were identified, with a high mortality rate (47 deaths, 24 injuries).
  • The mean age of affected patients was 74 years.
  • Women constituted a significantly higher proportion of cases (52/71) compared to men (10/71).

Conclusions:

  • Women appear to be at a significantly increased risk of PA rupture after PA catheterization.
  • Healthcare providers should maintain heightened awareness of this potential complication.
Abstract